Loading...
Loading...
In a report published Wednesday, Stifel analyst Shlomo Rosenbaum initiated coverage on
IMS Health HoldingsIMS with a Buy rating and $29.00 price target.
In the report, Stifel noted, “We are initiating coverage of IMS Health Holdings, Inc. (IMS) with a Buy rating on the shares. Our $29 target price assumes the company will achieve about a 5% FCF yield on our 2015 FCF estimates, and is consistent with the average FCF yield of the Business Information Services group on 2014 estimates. This valuation implies about 18.3x 2015 adjusted EPS, roughly similar to the EPS multiples of EFX and NLSN on 2014 numbers – we are assuming current valuation metrics carry forward to 2015.”
IMS Health Holdings closed on Tuesday at $25.21.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in